ArticleBMJ open2019

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol.

Sina Vatandoust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.